Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-14

Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, pharmacokinetics, and preliminary efficacy of ABBV-399 in participants with advanced solid tumors; status is active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABBV-399

Snippet

Sponsor: AbbVie | Conditions: Advanced Solid Tumors Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING